Krebs Biochemicals & Industries reports standalone net loss of Rs 11.31 crore in the March 2022 quarter

Sales rise 36.19% to Rs 17.80 crore

Net Loss of Krebs Biochemicals & Industries reported to Rs 11.31 crore in the quarter ended March 2022 as against net loss of Rs 6.99 crore during the previous quarter ended March 2021. Sales rose 36.19% to Rs 17.80 crore in the quarter ended March 2022 as against Rs 13.07 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 44.53 crore in the year ended March 2022 as against net loss of Rs 28.36 crore during the previous year ended March 2021. Sales rose 37.11% to Rs 52.94 crore in the year ended March 2022 as against Rs 38.61 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales17.8013.07 36 52.9438.61 37 OPM %-54.89-34.66 --64.22-45.53 - PBDT-9.26-5.58 -66 -38.23-23.24 -65 PBT-11.31-6.99 -62 -44.53-28.36 -57 NP-11.31-6.99 -62 -44.53-28.36 -57

Powered by Capital Market - Live News